0001213900-23-010983.txt : 20230213
0001213900-23-010983.hdr.sgml : 20230213
20230213213931
ACCESSION NUMBER: 0001213900-23-010983
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230209
FILED AS OF DATE: 20230213
DATE AS OF CHANGE: 20230213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TAGLIAFERRI MARY
CENTRAL INDEX KEY: 0001323304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 23621599
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
ownership.xml
X0306
4
2023-02-09
0
0000316253
ENZO BIOCHEM INC
ENZ
0001323304
TAGLIAFERRI MARY
C/O ENZO BIOCHEM, INC.
81 EXECUTIVE BLVD. SUITE 3
FARMINGDALE
NY
11735
1
0
0
0
Common Stock, $0.01 Par Value
2023-02-09
4
A
0
75188
0
A
155917
D
The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., February 9, 2024), or (ii) a change of control event.
/s/ Mary Tagliaferri
2023-02-13